Join
Live feed
·
INSIDERFilingvia Quantisnow
Emergent BioSolutions Inc. logo

EVP, Quality & Ethics, and CPL Glessner Coleen sold $306,080 worth of shares (30,608 units at $10.00), decreasing direct ownership by 17% to 144,319 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
EBS· Emergent BioSolutions Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EBS (Emergent BioSolutions Inc.) and more on Quantisnow.